Market Research Logo

Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review

Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-3196 (orally administered), is a proprietary, liver-directed, selective thyroid hormone receptor beta, (THR-ß), agonist that can potentially be used for treating several disease with high unmet medical need. The company is developing MGL-3196 for non-alcoholic steatohepatitis (NASH) and familial hypercholesterolemia (FH). The company is also developing MGL-3745 (THR-ß agonist), a preclinical compound that has similar thyroid receptor selectivity to MGL-3196. Madrigal is also headquartered in West Conshohocken, Pennsylvania, the US.

Madrigal Pharmaceuticals Inc Key Recent Developments

May 08,2018: Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements
Mar 13,2018: Madrigal Pharmaceuticals Reports 2017 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Clinical Update on MGL-3196
Nov 09,2017: Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results
Aug 10,2017: Madrigal Pharmaceuticals Reports 2017 Second Quarter Financial Results
May 11,2017: Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Madrigal Pharmaceuticals Inc - Key Facts
Madrigal Pharmaceuticals Inc - Key Employees
Madrigal Pharmaceuticals Inc - Key Employee Biographies
Madrigal Pharmaceuticals Inc - Major Products and Services
Madrigal Pharmaceuticals Inc - History
Madrigal Pharmaceuticals Inc - Company Statement
Madrigal Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Madrigal Pharmaceuticals Inc - Business Description
Madrigal Pharmaceuticals Inc - Corporate Strategy
Madrigal Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Madrigal Pharmaceuticals Inc - Strengths
Madrigal Pharmaceuticals Inc - Weaknesses
Madrigal Pharmaceuticals Inc - Opportunities
Madrigal Pharmaceuticals Inc - Threats
Madrigal Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Madrigal Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 08, 2018: Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements
Mar 13, 2018: Madrigal Pharmaceuticals Reports 2017 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Clinical Update on MGL-3196
Nov 09, 2017: Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results
Aug 10, 2017: Madrigal Pharmaceuticals Reports 2017 Second Quarter Financial Results
May 11, 2017: Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results
Apr 03, 2017: Madrigal Pharmaceuticals Reports 2016 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Update on Lead Clinical-stage Compound, MGL-3196
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Madrigal Pharmaceuticals Inc, Key Facts
Madrigal Pharmaceuticals Inc, Key Employees
Madrigal Pharmaceuticals Inc, Key Employee Biographies
Madrigal Pharmaceuticals Inc, Major Products and Services
Madrigal Pharmaceuticals Inc, History
Madrigal Pharmaceuticals Inc, Subsidiaries
Madrigal Pharmaceuticals Inc, Key Competitors
Madrigal Pharmaceuticals Inc, Ratios based on current share price
Madrigal Pharmaceuticals Inc, Annual Ratios
Madrigal Pharmaceuticals Inc, Annual Ratios (Cont...1)
Madrigal Pharmaceuticals Inc, Interim Ratios
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Madrigal Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Madrigal Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Madrigal Pharmaceuticals Inc, Ratio Charts
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report